Log In
BCIQ
Print this Print this
 

Alvesco, ciclesonide (inhaled)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionInhaled corticosteroid
Molecular Target Corticoid receptors
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAsthma
Indication DetailsTreat asthma
Regulatory Designation
PartnerSumitomo Dainippon Pharma Co. Ltd.;
Teijin Pharma Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$575.0M

$575.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/16/2015

$575.0M

$575.0M

0

Get a free BioCentury trial today